Navigation Links
Vasoguard Microlite Vascular Doppler

ProductsVasoguard Microlite Vascular Doppler
Company VIASYS Healthcare (Nicolet Biomedical)
Item Vasoguard Microlite Vascular Doppler
Features 
  • Windows XP operating system
  • Full FFT color spectral analysis with both 8 and 4 MHz Doppler transducers
  • Doppler Autogain for optimum waveform acquisition
  • Auto-calculations for quantifiable Doppler parameters
  • Calibrated, dual-channel Pulse Volume Recording (PVR) with cuff air-volume display
  • Dual channel ultra-sensitive photoplethysmography (PPG) with unique holder clip for tape-free application
  • Unique "thumb nail" reports for fast, complete review of report pages before printing
  • Full-featured remote control, available in wired or optional cordless infrared configuration
Description This exciting product from Viasys Neurocare is a full-featured physiologic testing system offered in a small, compact and portable size. It contains many of the features of our flagship system, the VasoGuard, and is offered at an economical price.

The smaller size of the Microlite makes it ideal for a crowded lab environment, the physician's office, a mobile service or anywhere space is at a premium.

Despite it's compact size, the Microlite is a computer-based system with a large memory for storing thousands of patient studies.

Info VIASYS Healthcare (Nicolet Biomedical)
Customer Service: (800) 356-0007
Web site: http://www.nicoletbiomedical.com/

Related medicine products :

1. Vasoguard Vascular Doppler
2. Microlite
3. Vascular Clamps B-1
4. Vascular Clamps B-2
5. Vascular Clamps B-3
6. Vascular Clamps HD-S
7. Vascular Clamps RD-S
8. Vascular Clamps ABB-11
9. VersaLab Vascular Doppler
10. PINNACLE Introducer Sheath Designed for Vascular Access
11. CVS4 Complete Vascular System
...rgery, and the accompanying need for patient hemod...aft be developed. Grafts must not only be strong, ...ying sizes and configurations for improved vascula...e prosthetic of choice among vascular surgeons wor...
...t vascular graft offering from W. L. Gore & Associ...ore than two decades, redefines graft performance ... can lead to complications post-surgery. This new ... without the rings. Employing a patented, unibody...
...t vascular graft offering from W. L. Gore & Associ...ore than two decades, redefines graft performance ... can lead to complications post-surgery. This new ... without the rings. Employing a patented, unibody...
Vikingselect™ Intra-Operative Monitoring (IOM).
Medicine Products:
(Date:9/8/2008)...eople who received gene therapy at the University ...dness have regained some of their vision, accordin... Therapy . , The patients one woman and two men...reditary blindness called Leber congenital amauros...perimental gene-transfer technique in a phase 1 cl...
(Date:9/8/2008)...onsoring campus events, giveaways, lung associatio...ews) -- Fewer U.S. college students (1 in 5) are s...ty leaders need to take a stand against aggressive...ent smoking rates don,t increase, a new American L...universities have a responsibility to provide safe...
(Date:9/8/2008)...-FirstCall/ -- NutraCea (OTC Bulletin,Board: NTRZ)...and,technology, announced today the U.S. Chamber o...NutraCea as a finalist for a Corporate Citizenship...mall/Midsize Business., "There are many strong ca... year," said BCLC Executive Director Stephen Jorda...
(Date:9/8/2008)...s Program Proves Cost-Saving for Employers ...MENTO, Calif., Sept. 8 /PRNewswire/ -- Kurt Wetzel...R.N., is completing triathlons. Marcia,Augsburger ...f stress and,burnout among the attorneys and staff...ent study shows that employers are seeing initial ...
Breaking Medicine News(10 mins):Health News:Safety study indicates gene therapy for blindness improves vision 2Health News:Safety study indicates gene therapy for blindness improves vision 3Health News:Fewer College Kids Smoking, But Industry Tactics a Threat 2Health News:Fewer College Kids Smoking, But Industry Tactics a Threat 3Health News:U.S. Chamber Recognizes NutraCea for Strong Corporate Stewardship 2Health News:'Live Well for Life' Benefits Companies and Workers 2Health News:'Live Well for Life' Benefits Companies and Workers 3Health News:'Live Well for Life' Benefits Companies and Workers 4
... those who cared for grandchildren at least nine h...rt attack. It's probably the stress, said research...ng factors, it is likely that caregivers have so m...e time and energy to follow basic preventive healt...
... before having a heart attack may be very differen...esearchers interviewed more than 500 women who exp...ive different medical sites. The average age of th...d the women to identify their symptoms before thei...
...s with high density lipoprotein may reverse years ...eveland Clinic injected patients with a laboratory...ch naturally removes fatty buildups from arteries.... HDL, and 11 patients who served as a control grou...
...hritis of the knee back to the future.They find ap...eve pain and other symptoms better than traditiona...s to treat pain is an ancient medical practice. Al...arity with the introduction of modern surgery and ...
Other Medicine News:
(Date:9/4/2008)...on for the treatment of Acute Myeloid ...t. 4 /- Celator Pharmaceuticals today...n (FDA) has granted orphan,drug designation to CPX...for the treatment of Acute Myeloid Leukemia (AML)....andomized Phase 2,studies with CPX-351. The first ...
(Date:9/4/2008)...wswire/ -- Southern Research Institute,today annou...has selected,the organization to participate in th...n Center Network (MLPCN). The MLPCN -- a collabora...Libraries Program which is,designed to benefit hum...an,genome and validate future targets for drug dis...
(Date:9/4/2008)...tification for Targeted Therapies Tha...TINGTON BEACH, Calif., and AMSTERDAM, Netherlands,...n molecular cancer diagnostics,today announced th...that,allows physicians to quantitatively determine...or (ER), progesterone receptor (PR) and Human Epid...
(Date:9/3/2008)...ogy Research and Education Foundation,s Within Ou...tecting, Treating and Understa...e first time during its,unprecedented initiative t...an College of Rheumatology Research and Education ...rom research funded by the Within Our,Reach: Findi...
Breaking Medicine Technology:Celator Pharmaceuticals Receives Orphan Drug Designation for Anticancer Agent CPX-351 2Southern Research Institute Wins $14.7 Million NIH Award to Participate in Molecular Libraries Probe Production Center Network 2Southern Research Institute Wins $14.7 Million NIH Award to Participate in Molecular Libraries Probe Production Center Network 3Southern Research Institute Wins $14.7 Million NIH Award to Participate in Molecular Libraries Probe Production Center Network 4Agendia Launches TargetPrint(R) for Breast Cancer Patients 2New Research Shows Promise for Finding A Cure for Rheumatoid Arthritis 2New Research Shows Promise for Finding A Cure for Rheumatoid Arthritis 3Fat Cells in Obese People Are Sick 25837 1Magnesium Sulfate Reduces Threat of Cerebral Palsy 25835 1Magnesium Sulfate Reduces Threat of Cerebral Palsy 25835 2Magnesium Sulfate Reduces Threat of Cerebral Palsy 25835 3Newer Blood Pressure Drug No Better Than Placebo in Preventing Stroke 25833 1Newer Blood Pressure Drug No Better Than Placebo in Preventing Stroke 25833 2Newer Blood Pressure Drug No Better Than Placebo in Preventing Stroke 25833 3Reese Witherspoon Visits Brazil to Spread Message of Female Empowerment as Avons Global Ambassador 25831 1Reese Witherspoon Visits Brazil to Spread Message of Female Empowerment as Avons Global Ambassador 25831 2
...E, Mass.--(BUSINESS WIRE)--Jun 8, 2007 - Archemix ...ing and developing,aptamers, announced the success...amer therapeutic, ARC1779. ARC1779 is designed to,...regation of,platelets by inhibiting the binding of...on platelets. Activated vWF is scientifically,reco...
...CKEN, Pa.--(BUSINESS WIRE)--Jun 8, 2007 - NuPathe ...mpany, today announced,positive results from an in...treatment for acute migraine being developed,by Nu...roprietary,iontophoretic transdermal technology wi...nt for acute migraine in the United,States. Sumatr...
Other Medicine Technology:Archemix Announces Completion of Phase 1 Trial of ARC1779 2Archemix Announces Completion of Phase 1 Trial of ARC1779 3NuPathe Reports Positive Phase One Results for NP101 Transdermal,Therapy for Acute Migraine 2NuPathe Reports Positive Phase One Results for NP101 Transdermal,Therapy for Acute Migraine 3